[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$feS9x8edhbK51ZAENNq3xBRl33rmoaPPByzlC57h60wQ":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":32,"phaseBuckets":38,"rows":45},"University of Helsinki",[4],132,false,21,7,326899,1,106,[14,17,19,21,23,25,27,30],{"name":15,"count":16},"Atherosclerosis",3,{"name":18,"count":16},"Colorectal Cancer",{"name":20,"count":16},"Cardiovascular Diseases",{"name":22,"count":16},"Language Development",{"name":24,"count":16},"BPH (Benign Prostatic Hyperplasia)",{"name":26,"count":16},"Periodontitis",{"name":28,"count":29},"Type2 Diabetes",2,{"name":31,"count":29},"Well-Being, Psychological",[33],{"nctId":34,"briefTitle":35,"date":36,"intervention":37},"NCT06117384","Systems Oncology Approach to Optimize Ovarian Cancer Treatment","2027-12-31","Biomolecular profiling",[39,40,41,42,43,44],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[46,69,109,134,160,187,205,232,250,275,301,319,345,371,397,422,448,476,494,512,539,557,580,607,625,651,669,694,720,745,774,802,827,854,872],{"intervention":37,"totalTrials":11,"cells":47},{"EARLY_PHASE1":48,"PHASE1":51,"PHASE2":53,"PHASE3":55,"PHASE4":57,"NA":59},{"trials":49,"activeCount":50},[],0,{"trials":52,"activeCount":50},[],{"trials":54,"activeCount":50},[],{"trials":56,"activeCount":50},[],{"trials":58,"activeCount":50},[],{"trials":60,"activeCount":11,"soonestReadout":36},[61],{"nctId":34,"briefTitle":35,"status":62,"phases":63,"primaryCompletion":36,"completion":36,"start":64,"enrollment":65,"conditions":66,"interventions":68},"RECRUITING",[],"2022-01-01",500,[67],"Ovarian Cancer",[37],{"intervention":70,"totalTrials":29,"cells":71},"montelukast",{"EARLY_PHASE1":72,"PHASE1":74,"PHASE2":76,"PHASE3":78,"PHASE4":80,"NA":107},{"trials":73,"activeCount":50},[],{"trials":75,"activeCount":50},[],{"trials":77,"activeCount":50},[],{"trials":79,"activeCount":50},[],{"trials":81,"activeCount":50},[82,94],{"nctId":83,"briefTitle":84,"status":85,"phases":86,"primaryCompletion":87,"completion":87,"start":88,"enrollment":89,"conditions":90,"interventions":93},"NCT00934713","The Effect of Montelukast Treatment in Wheezy Infants","COMPLETED",[43],"2008-04","2004-09",112,[91,92],"Lung Disease, Obstructive","Signs and Symptoms, Respiratory",[70],{"nctId":95,"briefTitle":96,"status":85,"phases":97,"completion":98,"start":99,"enrollment":100,"conditions":101,"interventions":106},"NCT00559546","Montelukast as a Controller of Atopic Syndrome",[43],"2007-07","2007-03",61,[102,103,104,105],"Seasonal Allergic Rhinitis","Allergic Conjunctivitis","Atopic Eczema","Asthma",[70],{"trials":108,"activeCount":50},[],{"intervention":110,"totalTrials":11,"cells":111},"Levodopa",{"EARLY_PHASE1":112,"PHASE1":114,"PHASE2":116,"PHASE3":118,"PHASE4":120,"NA":132},{"trials":113,"activeCount":50},[],{"trials":115,"activeCount":50},[],{"trials":117,"activeCount":50},[],{"trials":119,"activeCount":50},[],{"trials":121,"activeCount":50},[122],{"nctId":123,"briefTitle":124,"status":85,"phases":125,"primaryCompletion":126,"completion":126,"start":127,"enrollment":128,"conditions":129,"interventions":131},"NCT00914134","Duodenal Levodopa Infusion, Quality of Life and Autonomic Nervous System in Parkinson's Disease",[43],"2011-01","2009-04",12,[130],"Parkinson's Disease",[110],{"trials":133,"activeCount":50},[],{"intervention":135,"totalTrials":11,"cells":136},"dehydroepiandrosterone",{"EARLY_PHASE1":137,"PHASE1":139,"PHASE2":141,"PHASE3":143,"PHASE4":145,"NA":158},{"trials":138,"activeCount":50},[],{"trials":140,"activeCount":50},[],{"trials":142,"activeCount":50},[],{"trials":144,"activeCount":50},[],{"trials":146,"activeCount":50},[147],{"nctId":148,"briefTitle":149,"status":150,"phases":151,"completion":152,"start":153,"enrollment":154,"conditions":155,"interventions":157},"NCT00543166","Sex Steroids in Sjögren's Syndrome: Effect of Substitution Treatment on Fatigue","UNKNOWN",[43],"2009-12","2003-02",107,[156],"Sjogren's Syndrome",[135],{"trials":159,"activeCount":50},[],{"intervention":161,"totalTrials":11,"cells":162},"Trexan+Salazopyrin+Oxiklorin+prednisolone + infliximab",{"EARLY_PHASE1":163,"PHASE1":165,"PHASE2":167,"PHASE3":169,"PHASE4":171,"NA":185},{"trials":164,"activeCount":50},[],{"trials":166,"activeCount":50},[],{"trials":168,"activeCount":50},[],{"trials":170,"activeCount":50},[],{"trials":172,"activeCount":50},[173],{"nctId":174,"briefTitle":175,"status":150,"phases":176,"primaryCompletion":177,"completion":178,"start":179,"enrollment":180,"conditions":181,"interventions":183},"NCT00908089","TNF-blocking Therapy in Combination With Disease-modifying Antirheumatic Drugs in Early Rheumatoid Arthritis",[43],"2007-05","2015-12","2003-03",100,[182],"Rheumatoid Arthritis",[161,184],"Trexan+Salazopyrin+Oxiklorin+prednisolone + placebo",{"trials":186,"activeCount":50},[],{"intervention":184,"totalTrials":11,"cells":188},{"EARLY_PHASE1":189,"PHASE1":191,"PHASE2":193,"PHASE3":195,"PHASE4":197,"NA":203},{"trials":190,"activeCount":50},[],{"trials":192,"activeCount":50},[],{"trials":194,"activeCount":50},[],{"trials":196,"activeCount":50},[],{"trials":198,"activeCount":50},[199],{"nctId":174,"briefTitle":175,"status":150,"phases":200,"primaryCompletion":177,"completion":178,"start":179,"enrollment":180,"conditions":201,"interventions":202},[43],[182],[161,184],{"trials":204,"activeCount":50},[],{"intervention":206,"totalTrials":11,"cells":207},"HES",{"EARLY_PHASE1":208,"PHASE1":210,"PHASE2":212,"PHASE3":214,"PHASE4":216,"NA":230},{"trials":209,"activeCount":50},[],{"trials":211,"activeCount":50},[],{"trials":213,"activeCount":50},[],{"trials":215,"activeCount":50},[],{"trials":217,"activeCount":50},[218],{"nctId":219,"briefTitle":220,"status":85,"phases":221,"primaryCompletion":222,"completion":222,"start":223,"enrollment":224,"conditions":225,"interventions":228},"NCT00797589","Effect of Prime Solution on Fluid Balance After Open Heart Surgery",[43],"2012-09","2009-01",35,[226,227],"Valve Surgery","Coronary Artery Bypass Grafting",[206,229],"Ringer lactate",{"trials":231,"activeCount":50},[],{"intervention":229,"totalTrials":11,"cells":233},{"EARLY_PHASE1":234,"PHASE1":236,"PHASE2":238,"PHASE3":240,"PHASE4":242,"NA":248},{"trials":235,"activeCount":50},[],{"trials":237,"activeCount":50},[],{"trials":239,"activeCount":50},[],{"trials":241,"activeCount":50},[],{"trials":243,"activeCount":50},[244],{"nctId":219,"briefTitle":220,"status":85,"phases":245,"primaryCompletion":222,"completion":222,"start":223,"enrollment":224,"conditions":246,"interventions":247},[43],[226,227],[206,229],{"trials":249,"activeCount":50},[],{"intervention":251,"totalTrials":11,"cells":252},"Adalimumab",{"EARLY_PHASE1":253,"PHASE1":255,"PHASE2":257,"PHASE3":259,"PHASE4":261,"NA":273},{"trials":254,"activeCount":50},[],{"trials":256,"activeCount":50},[],{"trials":258,"activeCount":50},[],{"trials":260,"activeCount":50},[],{"trials":262,"activeCount":50},[263],{"nctId":264,"briefTitle":265,"status":150,"phases":266,"primaryCompletion":267,"completion":267,"start":268,"enrollment":269,"conditions":270,"interventions":272},"NCT02634541","Adalimumab in Alleviating Inflammation in Patients With Axial Spondyloarthritis",[43],"2017-12","2016-01",60,[271],"Ankylosing Spondyloarthritis",[251],{"trials":274,"activeCount":50},[],{"intervention":276,"totalTrials":11,"cells":277},"Infusion with paracetamol",{"EARLY_PHASE1":278,"PHASE1":280,"PHASE2":282,"PHASE3":284,"PHASE4":286,"NA":299},{"trials":279,"activeCount":50},[],{"trials":281,"activeCount":50},[],{"trials":283,"activeCount":50},[],{"trials":285,"activeCount":50},[],{"trials":287,"activeCount":50},[288],{"nctId":289,"briefTitle":290,"status":85,"phases":291,"primaryCompletion":292,"completion":292,"start":293,"enrollment":294,"conditions":295,"interventions":297},"NCT01540838","Slow Initial β-lactam Infusion With High-dose Paracetamol to Improve the Outcomes of Childhood Bacterial Meningitis",[43],"2017-02","2012-02",375,[296],"Bacterial Meningitis",[276,298],"Bolus without paracetamol",{"trials":300,"activeCount":50},[],{"intervention":298,"totalTrials":11,"cells":302},{"EARLY_PHASE1":303,"PHASE1":305,"PHASE2":307,"PHASE3":309,"PHASE4":311,"NA":317},{"trials":304,"activeCount":50},[],{"trials":306,"activeCount":50},[],{"trials":308,"activeCount":50},[],{"trials":310,"activeCount":50},[],{"trials":312,"activeCount":50},[313],{"nctId":289,"briefTitle":290,"status":85,"phases":314,"primaryCompletion":292,"completion":292,"start":293,"enrollment":294,"conditions":315,"interventions":316},[43],[296],[276,298],{"trials":318,"activeCount":50},[],{"intervention":320,"totalTrials":11,"cells":321},"candesartan",{"EARLY_PHASE1":322,"PHASE1":324,"PHASE2":326,"PHASE3":328,"PHASE4":341,"NA":343},{"trials":323,"activeCount":50},[],{"trials":325,"activeCount":50},[],{"trials":327,"activeCount":50},[],{"trials":329,"activeCount":50},[330],{"nctId":331,"briefTitle":332,"status":150,"phases":333,"primaryCompletion":334,"completion":335,"start":336,"enrollment":337,"conditions":338,"interventions":340},"NCT00699452","The Potential of Candesartan to Retard the Progression of Aortic Stenosis",[42],"2012-12","2014-12","2009-05",120,[339],"Aortic Valve Stenosis",[320],{"trials":342,"activeCount":50},[],{"trials":344,"activeCount":50},[],{"intervention":346,"totalTrials":11,"cells":347},"Radioactive iodine",{"EARLY_PHASE1":348,"PHASE1":350,"PHASE2":352,"PHASE3":354,"PHASE4":367,"NA":369},{"trials":349,"activeCount":50},[],{"trials":351,"activeCount":50},[],{"trials":353,"activeCount":50},[],{"trials":355,"activeCount":50},[356],{"nctId":357,"briefTitle":358,"status":150,"phases":359,"primaryCompletion":360,"completion":361,"start":362,"enrollment":363,"conditions":364,"interventions":366},"NCT00115895","The Dose of Radioactive Iodine Needed to Ablate the Thyroid Remnant Left Behind After Thyroidectomy",[42],"2004-10","2020-09","2000-01",160,[365],"Thyroid Neoplasms",[346],{"trials":368,"activeCount":50},[],{"trials":370,"activeCount":50},[],{"intervention":372,"totalTrials":11,"cells":373},"Melatonin",{"EARLY_PHASE1":374,"PHASE1":376,"PHASE2":378,"PHASE3":380,"PHASE4":393,"NA":395},{"trials":375,"activeCount":50},[],{"trials":377,"activeCount":50},[],{"trials":379,"activeCount":50},[],{"trials":381,"activeCount":50},[382],{"nctId":383,"briefTitle":384,"status":85,"phases":385,"primaryCompletion":386,"completion":386,"start":387,"enrollment":388,"conditions":389,"interventions":392},"NCT01705639","Melatonin and Glucose Tolerance Among Individuals With a Variant of the MTNR1B Gene",[42],"2014-08","2012-11",45,[390,391],"Diabetes","Glucose Tolerance",[372],{"trials":394,"activeCount":50},[],{"trials":396,"activeCount":50},[],{"intervention":398,"totalTrials":11,"cells":399},"LNG-IUS",{"EARLY_PHASE1":400,"PHASE1":402,"PHASE2":404,"PHASE3":406,"PHASE4":418,"NA":420},{"trials":401,"activeCount":50},[],{"trials":403,"activeCount":50},[],{"trials":405,"activeCount":50},[],{"trials":407,"activeCount":50},[408],{"nctId":409,"briefTitle":410,"status":85,"phases":411,"primaryCompletion":412,"completion":412,"start":413,"enrollment":414,"conditions":415,"interventions":417},"NCT00966264","Hysterectomy and Levonorgestrel Releasing Intrauterine System (LNG-IUS) in the Treatment of Menorrhagia",[42],"2008-10","1994-10",236,[416],"Menorrhagia",[398],{"trials":419,"activeCount":50},[],{"trials":421,"activeCount":50},[],{"intervention":423,"totalTrials":11,"cells":424},"Mixture of probiotic bacteria and prebiotic oligosaccharide",{"EARLY_PHASE1":425,"PHASE1":427,"PHASE2":429,"PHASE3":431,"PHASE4":444,"NA":446},{"trials":426,"activeCount":50},[],{"trials":428,"activeCount":50},[],{"trials":430,"activeCount":50},[],{"trials":432,"activeCount":50},[433],{"nctId":434,"briefTitle":435,"status":150,"phases":436,"completion":437,"start":438,"conditions":439,"interventions":443},"NCT00298337","Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008",[41,42],"2007-12","1999-10",[440,441,442,103,105],"Atopic Dermatitis","Food Hypersensitivity","Allergic Rhinitis, Seasonal",[423],{"trials":445,"activeCount":50},[],{"trials":447,"activeCount":50},[],{"intervention":449,"totalTrials":11,"cells":450},"Aspirin",{"EARLY_PHASE1":451,"PHASE1":453,"PHASE2":455,"PHASE3":457,"PHASE4":472,"NA":474},{"trials":452,"activeCount":50},[],{"trials":454,"activeCount":50},[],{"trials":456,"activeCount":50},[],{"trials":458,"activeCount":50},[459],{"nctId":460,"briefTitle":461,"status":85,"phases":462,"primaryCompletion":463,"completion":464,"start":465,"enrollment":466,"conditions":467,"interventions":469},"NCT00959621","Low Molecular Weight Heparin and\u002For Aspirin in Prevention of Habitual Abortion",[42],"2004-12","2008-12","2002-01",220,[468],"Habitual Abortion",[449,470,471],"Klexane","Klexane and ASA",{"trials":473,"activeCount":50},[],{"trials":475,"activeCount":50},[],{"intervention":470,"totalTrials":11,"cells":477},{"EARLY_PHASE1":478,"PHASE1":480,"PHASE2":482,"PHASE3":484,"PHASE4":490,"NA":492},{"trials":479,"activeCount":50},[],{"trials":481,"activeCount":50},[],{"trials":483,"activeCount":50},[],{"trials":485,"activeCount":50},[486],{"nctId":460,"briefTitle":461,"status":85,"phases":487,"primaryCompletion":463,"completion":464,"start":465,"enrollment":466,"conditions":488,"interventions":489},[42],[468],[449,470,471],{"trials":491,"activeCount":50},[],{"trials":493,"activeCount":50},[],{"intervention":471,"totalTrials":11,"cells":495},{"EARLY_PHASE1":496,"PHASE1":498,"PHASE2":500,"PHASE3":502,"PHASE4":508,"NA":510},{"trials":497,"activeCount":50},[],{"trials":499,"activeCount":50},[],{"trials":501,"activeCount":50},[],{"trials":503,"activeCount":50},[504],{"nctId":460,"briefTitle":461,"status":85,"phases":505,"primaryCompletion":463,"completion":464,"start":465,"enrollment":466,"conditions":506,"interventions":507},[42],[468],[449,470,471],{"trials":509,"activeCount":50},[],{"trials":511,"activeCount":50},[],{"intervention":513,"totalTrials":11,"cells":514},"Intramyocardial mesenchymal stem cell transplantation",{"EARLY_PHASE1":515,"PHASE1":517,"PHASE2":519,"PHASE3":533,"PHASE4":535,"NA":537},{"trials":516,"activeCount":50},[],{"trials":518,"activeCount":50},[],{"trials":520,"activeCount":50},[521],{"nctId":522,"briefTitle":523,"status":150,"phases":524,"primaryCompletion":152,"completion":525,"start":526,"enrollment":269,"conditions":527,"interventions":531},"NCT00418418","Combined CABG and Stem-Cell Transplantation for Heart Failure",[41],"2010-12","2006-10",[528,529,530],"Heart Failure","Myocardial Infarction","Coronary Artery Disease",[513,532],"Intramyocardial injection of autologous serum",{"trials":534,"activeCount":50},[],{"trials":536,"activeCount":50},[],{"trials":538,"activeCount":50},[],{"intervention":532,"totalTrials":11,"cells":540},{"EARLY_PHASE1":541,"PHASE1":543,"PHASE2":545,"PHASE3":551,"PHASE4":553,"NA":555},{"trials":542,"activeCount":50},[],{"trials":544,"activeCount":50},[],{"trials":546,"activeCount":50},[547],{"nctId":522,"briefTitle":523,"status":150,"phases":548,"primaryCompletion":152,"completion":525,"start":526,"enrollment":269,"conditions":549,"interventions":550},[41],[528,529,530],[513,532],{"trials":552,"activeCount":50},[],{"trials":554,"activeCount":50},[],{"trials":556,"activeCount":50},[],{"intervention":558,"totalTrials":11,"cells":559},"PTK787\u002FZK222584",{"EARLY_PHASE1":560,"PHASE1":562,"PHASE2":564,"PHASE3":574,"PHASE4":576,"NA":578},{"trials":561,"activeCount":50},[],{"trials":563,"activeCount":50},[],{"trials":565,"activeCount":50},[566],{"nctId":567,"briefTitle":568,"status":85,"phases":569,"primaryCompletion":570,"completion":223,"start":88,"enrollment":388,"conditions":571,"interventions":573},"NCT00117299","PTK787\u002FZK222584 in the Treatment of Metastatic Gastrointestinal Stromal Tumors Resistant to Imatinib",[41],"2007-09",[572],"Sarcoma",[558],{"trials":575,"activeCount":50},[],{"trials":577,"activeCount":50},[],{"trials":579,"activeCount":50},[],{"intervention":581,"totalTrials":11,"cells":582},"anakinra",{"EARLY_PHASE1":583,"PHASE1":585,"PHASE2":587,"PHASE3":601,"PHASE4":603,"NA":605},{"trials":584,"activeCount":50},[],{"trials":586,"activeCount":50},[],{"trials":588,"activeCount":50},[589],{"nctId":590,"briefTitle":591,"status":85,"phases":592,"primaryCompletion":593,"completion":594,"start":595,"enrollment":596,"conditions":597,"interventions":599},"NCT01033656","Treatment of Refractory Adult-onset Still's Disease With Anakinra: a Randomized Study",[41],"2010-03","2010-04","2005-12",23,[598],"Adult-Onset Still's Disease",[581,600],"comparators",{"trials":602,"activeCount":50},[],{"trials":604,"activeCount":50},[],{"trials":606,"activeCount":50},[],{"intervention":600,"totalTrials":11,"cells":608},{"EARLY_PHASE1":609,"PHASE1":611,"PHASE2":613,"PHASE3":619,"PHASE4":621,"NA":623},{"trials":610,"activeCount":50},[],{"trials":612,"activeCount":50},[],{"trials":614,"activeCount":50},[615],{"nctId":590,"briefTitle":591,"status":85,"phases":616,"primaryCompletion":593,"completion":594,"start":595,"enrollment":596,"conditions":617,"interventions":618},[41],[598],[581,600],{"trials":620,"activeCount":50},[],{"trials":622,"activeCount":50},[],{"trials":624,"activeCount":50},[],{"intervention":626,"totalTrials":11,"cells":627},"Psilocybin",{"EARLY_PHASE1":628,"PHASE1":630,"PHASE2":632,"PHASE3":645,"PHASE4":647,"NA":649},{"trials":629,"activeCount":50},[],{"trials":631,"activeCount":50},[],{"trials":633,"activeCount":50},[634],{"nctId":635,"briefTitle":636,"status":150,"phases":637,"primaryCompletion":638,"completion":639,"start":640,"enrollment":269,"conditions":641,"interventions":643},"NCT03380442","Psilocybin and Depression",[41],"2020-01","2021-09","2018-09",[642],"Severe Depression",[626,644],"Ketamine",{"trials":646,"activeCount":50},[],{"trials":648,"activeCount":50},[],{"trials":650,"activeCount":50},[],{"intervention":644,"totalTrials":11,"cells":652},{"EARLY_PHASE1":653,"PHASE1":655,"PHASE2":657,"PHASE3":663,"PHASE4":665,"NA":667},{"trials":654,"activeCount":50},[],{"trials":656,"activeCount":50},[],{"trials":658,"activeCount":50},[659],{"nctId":635,"briefTitle":636,"status":150,"phases":660,"primaryCompletion":638,"completion":639,"start":640,"enrollment":269,"conditions":661,"interventions":662},[41],[642],[626,644],{"trials":664,"activeCount":50},[],{"trials":666,"activeCount":50},[],{"trials":668,"activeCount":50},[],{"intervention":670,"totalTrials":11,"cells":671},"microbial inoculate",{"EARLY_PHASE1":672,"PHASE1":674,"PHASE2":686,"PHASE3":688,"PHASE4":690,"NA":692},{"trials":673,"activeCount":50},[],{"trials":675,"activeCount":50},[676],{"nctId":677,"briefTitle":678,"status":85,"phases":679,"primaryCompletion":680,"completion":681,"start":682,"enrollment":269,"conditions":683,"interventions":685},"NCT03351543","Effect of Microbial Exposure on Health, Particularly Immune System",[40],"2016-06","2017-07","2016-03",[684],"Immune System Disorders",[670],{"trials":687,"activeCount":50},[],{"trials":689,"activeCount":50},[],{"trials":691,"activeCount":50},[],{"trials":693,"activeCount":50},[],{"intervention":695,"totalTrials":11,"cells":696},"Ciprofloxacin",{"EARLY_PHASE1":697,"PHASE1":710,"PHASE2":712,"PHASE3":714,"PHASE4":716,"NA":718},{"trials":698,"activeCount":50},[699],{"nctId":700,"briefTitle":701,"status":85,"phases":702,"primaryCompletion":703,"completion":703,"start":704,"enrollment":705,"conditions":706,"interventions":709},"NCT02326103","Randomised Open-label Multicenter Study Evaluating Ciprofloxacin in Severe Alcoholic Hepatitis",[39],"2017-01","2015-04",22,[707,708],"Alcoholic Hepatitis","Alcoholic Cirrhosis",[695],{"trials":711,"activeCount":50},[],{"trials":713,"activeCount":50},[],{"trials":715,"activeCount":50},[],{"trials":717,"activeCount":50},[],{"trials":719,"activeCount":50},[],{"intervention":721,"totalTrials":11,"cells":722},"valproate",{"EARLY_PHASE1":723,"PHASE1":725,"PHASE2":727,"PHASE3":729,"PHASE4":731,"NA":733},{"trials":724,"activeCount":50},[],{"trials":726,"activeCount":50},[],{"trials":728,"activeCount":50},[],{"trials":730,"activeCount":50},[],{"trials":732,"activeCount":50},[],{"trials":734,"activeCount":50},[735],{"nctId":736,"briefTitle":737,"status":85,"phases":738,"primaryCompletion":739,"completion":739,"start":740,"enrollment":741,"conditions":742,"interventions":744},"NCT00570219","The Effect of Valproate on Benzodiazepine Withdrawal Severity",[44],"2008-05","2005-02",30,[743],"Substance Withdrawal Syndrome",[721],{"intervention":746,"totalTrials":11,"cells":747},"Nature-based materials",{"EARLY_PHASE1":748,"PHASE1":750,"PHASE2":752,"PHASE3":754,"PHASE4":756,"NA":758},{"trials":749,"activeCount":50},[],{"trials":751,"activeCount":50},[],{"trials":753,"activeCount":50},[],{"trials":755,"activeCount":50},[],{"trials":757,"activeCount":50},[],{"trials":759,"activeCount":50},[760],{"nctId":761,"briefTitle":762,"status":150,"phases":763,"primaryCompletion":764,"completion":765,"start":766,"enrollment":767,"conditions":768,"interventions":773},"NCT03872219","Biodiversity Intervention and Atopic Sensitization",[44],"2023-08-31","2025-12-31","2019-03-25",350,[769,770,771,772],"Atopy","Allergy","Allergic Rhinitis","Allergic Sensitisation",[746],{"intervention":775,"totalTrials":11,"cells":776},"trovafloxacin and levofloxacin",{"EARLY_PHASE1":777,"PHASE1":779,"PHASE2":781,"PHASE3":783,"PHASE4":785,"NA":787},{"trials":778,"activeCount":50},[],{"trials":780,"activeCount":50},[],{"trials":782,"activeCount":50},[],{"trials":784,"activeCount":50},[],{"trials":786,"activeCount":50},[],{"trials":788,"activeCount":50},[789],{"nctId":790,"briefTitle":791,"status":85,"phases":792,"completion":793,"start":794,"enrollment":795,"conditions":796,"interventions":801},"NCT00548002","Combination Therapy With Fluoroquinolone in Staphylococcus Aureus Bacteremia",[],"2002-08","1999-01",430,[797,798,799,800],"Staphylococcus Aureus","Bacteremia","Endocarditis","Sepsis",[775],{"intervention":803,"totalTrials":11,"cells":804},"ofloxacin and roxithromycin",{"EARLY_PHASE1":805,"PHASE1":807,"PHASE2":809,"PHASE3":811,"PHASE4":813,"NA":815},{"trials":806,"activeCount":50},[],{"trials":808,"activeCount":50},[],{"trials":810,"activeCount":50},[],{"trials":812,"activeCount":50},[],{"trials":814,"activeCount":50},[],{"trials":816,"activeCount":50},[817],{"nctId":818,"briefTitle":819,"status":85,"phases":820,"completion":821,"start":822,"enrollment":823,"conditions":824,"interventions":826},"NCT00621387","Study of Long-Term Antibiotic Treatment in Reactive Arthritis",[44],"1998-06","1993-11",56,[825],"Reactive Arthritis",[803],{"intervention":828,"totalTrials":11,"cells":829},"17-b-estradiol",{"EARLY_PHASE1":830,"PHASE1":832,"PHASE2":834,"PHASE3":836,"PHASE4":838,"NA":840},{"trials":831,"activeCount":50},[],{"trials":833,"activeCount":50},[],{"trials":835,"activeCount":50},[],{"trials":837,"activeCount":50},[],{"trials":839,"activeCount":50},[],{"trials":841,"activeCount":50},[842],{"nctId":843,"briefTitle":844,"status":85,"phases":845,"primaryCompletion":846,"completion":846,"start":847,"enrollment":363,"conditions":848,"interventions":851},"NCT00668603","Comparison of Vascular Findings Between Symptomatic and Asymptomatic Postmenopausal Women Before and During Hormone Therapy (HRT)",[44],"2008-03","2005-08",[849,850],"Postmenopausal Vasomotor Symptoms","Cardiovascular Disease",[828,852,853],"17-b-estradiol + medroxyprogeterone acetate","17-b-estradiol hemihydrate",{"intervention":852,"totalTrials":11,"cells":855},{"EARLY_PHASE1":856,"PHASE1":858,"PHASE2":860,"PHASE3":862,"PHASE4":864,"NA":866},{"trials":857,"activeCount":50},[],{"trials":859,"activeCount":50},[],{"trials":861,"activeCount":50},[],{"trials":863,"activeCount":50},[],{"trials":865,"activeCount":50},[],{"trials":867,"activeCount":50},[868],{"nctId":843,"briefTitle":844,"status":85,"phases":869,"primaryCompletion":846,"completion":846,"start":847,"enrollment":363,"conditions":870,"interventions":871},[44],[849,850],[828,852,853],{"intervention":853,"totalTrials":11,"cells":873},{"EARLY_PHASE1":874,"PHASE1":876,"PHASE2":878,"PHASE3":880,"PHASE4":882,"NA":884},{"trials":875,"activeCount":50},[],{"trials":877,"activeCount":50},[],{"trials":879,"activeCount":50},[],{"trials":881,"activeCount":50},[],{"trials":883,"activeCount":50},[],{"trials":885,"activeCount":50},[886],{"nctId":843,"briefTitle":844,"status":85,"phases":887,"primaryCompletion":846,"completion":846,"start":847,"enrollment":363,"conditions":888,"interventions":889},[44],[849,850],[828,852,853]]